Sign inJoin waitlistJoin the waitlist

William Drobyski

Leader, Discovery and Developmental Therapeutics Program, MCW Cancer Center · Medical College of Wisconsin Affiliated Hospitals, Inc

Credentials: · · ·

History

Medical College of Wisconsin Affiliated Hospitals, Inc
Present

Medical College of Wisconsin
1990–1993
Medical College of Wisconsin - Milwaukee
1988–1990
Internal Medicine
University of Rochester Medicine
1983–1986
University of Rochester School of Medicine and Dentistry
1979–1983

Research

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
Journal of Clinical Oncology · 1997 · 1,031 citations
Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction
Journal of Clinical Oncology · 1994 · 409 citations
Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research
Biology of Blood and Marrow Transplantation · 2015 · 370 citations

Parameswaran Hari
29 papers
Mary Horowitz
26 papers
Wael Saber
25 papers
Marcelo Pasquini
22 papers
RK
Richard Komorowski
22 papers
Anita D'Souza
18 papers · 1 as a fellow
TF
Timothy Fenske
17 papers
Saurabh Chhabra
13 papers
James Rizzo
12 papers
Binod Dhakal
11 papers
Bronwen Shaw
11 papers
JC
James Casper
11 papers

Grants

Augmenting Regulatory T Cell Reconstitution During GVHD
National Heart, Lung, and Blood Institute · R01
Contact PI · $675.4K · Medical College of Wisconsin
2026–2030
Inflammatory Cytokine Networks in Gastrointestinal Tract Graft Versus Host Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $5.4M · Medical College of Wisconsin
2015–2027
Mechanistic Inflammatory Pathways in Graft Versus Host Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.8M · Medical College of Wisconsin
2020–2026
Blockade of IL-23 for the Prevention of Graft Versus Host Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.2M · Medical College of Wisconsin
2021–2026

Clinical trials

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease
Principal investigator · Completed · Phase 2
Medical College of Wisconsin
2020–2024
PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant
Principal investigator · Completed · Phase 2
Medical College of Wisconsin
2018–2023
A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant
Principal investigator · Completed · Phase 2
William R. Drobyski, MD
2014–2018
Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Principal investigator · Terminated · Phase 1, Phase 2
Medical College of Wisconsin
2011–2018